Shalin Kothari, MD, is a hematologist and medical oncologist specializing in lymphoma. He serves as Assistant Professor of Medicine in the Section of Hematology at Yale University and practices as a clinician-scientist. His clinical focus includes lymphoid malignancies, complex hematologic oncology, and early-phase clinical trials for blood cancers. Dr. Kothari’s research centers on developing novel therapies for aggressive B-cell malignancies, elucidating mechanisms of response and resistance to lymphoma therapeutics, and translating discoveries into early-phase clinical trials. He leads as Clinician Lead for the Cancer Biology Training Program and serves as core faculty for the Medical Oncology and Hematology Fellowship. His honors include the K12 Immuno-Oncology Training Program Scholar Award, The DeLuca Center for Innovation in Hematology Career Development Award, the American Society of Hematology Abstract Achievement Award, recognition as a Lymphoma Research Foundation Scholar, and the Arnold P. Gold Humanism Award; he is also a member of the Lymphoma Research Foundation Mantle Cell Lymphoma Consortium and an inductee of the ASH Advocacy Leadership Institute and the Gold Humanism Honor Society. Dr. Kothari earned his medical degree from Gujarat University, completed internal medicine residency at SUNY Upstate Medical University, and a hematology and medical oncology fellowship at the University at Buffalo/Roswell Park Comprehensive Cancer Center, where he served as Chief Fellow.
Assistant Professor
Medical School
Residency
Fellowship